Since the discovery of BTK mutations as the cause of X-linked agammaglobulinemia (XLA) [18,19], the role of BTK in B-cell signaling has been extensively studied [1–3,12,20–22]. This evidence concerns the gene BTK and isolated agammaglobulinemia.